NCT02774486View on ClinicalTrials.gov

Efficacy and Safety of IQP-AK-102 in Reducing Appetite

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

July 20, 2016

Study Completion Date

July 20, 2016

Conditions
Appetite RegulationAppetite SuppressionEnergy Intake
Interventions
DEVICE

IQP-AK-102

IQP-AK-102 has been qualified as a medical device (CE certificate has been ob- tained), class IIb, according to MDD 93/42/EEC, annex IX, rule 5.

Trial Locations (1)

10709

Barbara Grube, Berlin

Sponsors

Lead Sponsor

InQpharm Group
All Listed Sponsors
lead

InQpharm Group

INDUSTRY